Showing results (501-510 of 1,523) with videos related to
Sort By:
Pageof 153
CPT: Pharmacometrics & Systems Pharmacology|November 18, 2020
Investigational Treatments for COVID-19 may Increase Ventricular Arrhythmia Risk Through Drug InteractionsMeera Varshneya, Itziar Irurzun-Arana, Chiara Campana, et al.CPT: Pharmacometrics & Systems Pharmacology|November 21, 2020
Examination of Physiologically-Based Pharmacokinetic Models of RosuvastatinChristine M Bowman, Fang Ma, Jialin Mao, et al.CPT: Pharmacometrics & Systems Pharmacology|February 18, 2020
Differentiating the Sodium-Glucose Cotransporter 1 Inhibition Capacity of Canagliflozin vs. Dapagliflozin and Empagliflozin Using Quantitative Systems Pharmacology ModelingVictor Sokolov, Tatiana Yakovleva, Lulu Chu, et al.CPT: Pharmacometrics & Systems Pharmacology|February 10, 2020
Efficient Pharmacokinetic Modeling Workflow With the MonolixSuite: A Case Study of RemifentanilPauline Traynard, Géraldine Ayral, Monika Twarogowska, et al.CPT: Pharmacometrics & Systems Pharmacology|February 10, 2020
A New Method to Model and Predict Progression Free Survival Based on Tumor Growth DynamicsJiajie Yu, Nina Wang, Matts KågedalCPT: Pharmacometrics & Systems Pharmacology|February 15, 2019
A Retrospective Evaluation of Allometry, Population Pharmacokinetics, and Physiologically-Based Pharmacokinetics for Pediatric Dosing Using Clearance as a SurrogateQier Wu, Sheila Annie PetersCPT: Pharmacometrics & Systems Pharmacology|January 26, 2019
Modeling Exposure-Driven Adverse Event Time Courses in Oncology Exemplified by AfatinibRonald Niebecker, Hugo Maas, Alexander Staab, et al.CPT: Pharmacometrics & Systems Pharmacology|January 20, 2019
Assessing Potential Drug-Drug Interactions Between Dabigatran Etexilate and a P-Glycoprotein Inhibitor in Renal Impairment Populations Using Physiologically Based Pharmacokinetic ModelingKosuke Doki, Sibylle Neuhoff, Amin Rostami-Hodjegan, et al.CPT: Pharmacometrics & Systems Pharmacology|November 1, 2019
Predicting Paclitaxel Disposition in Humans With Whole-Body Physiologically-Based Pharmacokinetic ModelingQiang Fu, Xinxin Sun, Maryam B Lustburg, et al.CPT: Pharmacometrics & Systems Pharmacology|November 2, 2019
Quantitative Systems Pharmacology for Neuroscience Drug Discovery and Development: Current Status, Opportunities, and ChallengesHugo Geerts, John Wikswo, Piet H van der Graaf, et al.Pageof 153